2nd Quarter - Report

WINNING STRATEGIES WASHINGTON for KALEO

Period 2nd Quarter 2023 Filed Jul 18, 2023 Signed by Michael Merola, Managing Partner

Official filing
Firm
WINNING STRATEGIES WASHINGTON
Client
KALEO
Income
$10,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Aviation/Airlines/Airports AVI

FAA reauthorization provisions related to emergency medicine.

LobbyistCovered position, as disclosed
SCOTT MACKENZIE Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Legislation related to prescription drug prices, including the implementation of Inflation Reduction Act (IRA); access to epinephrine in schools and other community settings

LobbyistCovered position, as disclosed
SCOTT MACKENZIE Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues

LobbyistCovered position, as disclosed
SCOTT MACKENZIE Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Medical countermeasures research and development

LobbyistCovered position, as disclosed
SCOTT MACKENZIE Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)
MICHAEL A MEROLA Deputy CoS, Sen. Torricelli
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Medical countermeasures research and development

LobbyistCovered position, as disclosed
SCOTT MACKENZIE Senior Policy Advisor, Rep. John Culberson (TX); Legislative Director, Rep. Daniel Webster (FL)
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.